Preferred Label : IGF1R Antiapoptosis Pathway;
NCIt related terms : Multiple antiapoptotic pathways from IGF-1R signaling lead to BAD phosphorylation;
Alternative definition : BIOCARTA: IGF-1R, the type 1 receptor for insulin-like growth factor, mediates cell
survival and growth in response to its ligands IGF-1 and IGF-2. This tyrosine kinase
receptor is widely expressed in many cell types and is a key mediator of growth. Overexpression
or activation of IGF-1R may be involved in the proliferation of transformed cells,
making inhibition of IGF-1R signaling a strategy for the development of cancer drugs.
IGF-1R activates three signaling pathways that converge to phosphorylate BAD protein
and block apoptosis. The first pathway activated by IGF-1R stimulates PI3-kinase and
the AKT pathway to phosphorylate BAD and block apoptosis. A second pathway activated
by IGF-1R involves ras mediated activation of the map kinase pathway to block apoptosis.
A third pathway involves interaction of raf with mitochondria in response to IGF-1R
activation. The convergence of these pathways to block apoptosis may enhance the IGF-1R
response. (This definition may be outdated - see the DesignNote.);
NCIt note : The BIOCARTA Definition (ALT_DEFINITION) for this pathway concept was provided by
BioCarta. This property was not created by, nor is it maintained by the NCI Thesaurus
staff. Additionally, BioCarta is no longer updating its pathway data; thus, the BIOCARTA
Definition might be outdated or inaccurate. Please see the Terms and Conditions for
Use at http://www.biocarta.com/.;
Biocarta ID : h_igf1rPathway;
Origin ID : C39115;
UMLS CUI : C1512585;
Semantic type(s)
has_gene_product_element
pathway_has_gene_element